Supplemental material
Journal of Extracellular Vesicles
Volume 8, 2019 - Issue 1
Research Article
Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
, , 
, , , , , , & show all
Martino AmbrosiniDepartment of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0003-1615-2984View further author information
https://orcid.org/0000-0003-1615-2984View further author information, , , , , , Yvette Van KooykDepartment of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0001-5997-3665View further author information
https://orcid.org/0000-0001-5997-3665View further author information & Juan J. Garcia-VallejoDepartment of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-6238-7069View further author information
https://orcid.org/0000-0001-6238-7069View further author information show allRelated Research Data
Cutting Edge: Carbohydrate Profiling Identifies New Pathogens That Interact with Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin on Dendritic Cells
Source:
The American Association of Immunologists
Targeting Dendritic Cells in vivo for Cancer Therapy
Source:
Frontiers Media SA
Personalized vaccines use tumour fingerprint to target glioblastoma.
Source:
Springer Science and Business Media LLC
Dendritic cells: specialized and regulated antigen processing machines.
Source:
Elsevier BV
Siglecs and their roles in the immune system
Source:
Springer Science and Business Media LLC
Actively personalized vaccination trial for newly diagnosed glioblastoma
Source:
Springer Science and Business Media LLC
Immunotherapeutic Advancements for Glioblastoma
Source:
Frontiers Media SA
HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin.
Source:
Springer Science and Business Media LLC
Quantification and size-profiling of extracellular vesicles using tunable resistive pulse sensing.
Source:
MyJove Corporation
Recent advances in antigen processing and presentation
Source:
Springer Science and Business Media LLC
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
Source:
Nature Publishing Group
Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity
Source:
Proceedings of the National Academy of Sciences
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Source:
Springer Science and Business Media LLC
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation
Source:
Elsevier BV
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Source:
Elsevier BV
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Source:
American Society for Clinical Investigation
Structural and functional features of central nervous system lymphatic vessels
Source:
Springer Science and Business Media LLC
Glioblastoma Vesicles Affect Monocytic Cells
Source:
Wiley
Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Source:
Elsevier BV
Current state of immunotherapy for glioblastoma
Source:
Nature Publishing Group
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
Source:
Springer Nature
Malignant effusions and immunogenic tumour-derived exosomes
Source:
Elsevier BV
Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages
Source:
HAL CCSD
Exosome removal as a therapeutic adjuvant in cancer
Source:
Springer Nature
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Source:
Springer Science and Business Media LLC
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Source:
Nature Publishing Group
Linking provided by
